Premium Essay

Investigational New Drug Review Process

In: Science

Submitted By prashanth123
Words 1524
Pages 7
INVESTIGATIONAL NEW DRUG REVIEW PROCESS

Investigational New Drug Review Process
Prashanth Kumar Ponugoti
Northeastern University

INVESTIGATIONAL NEW DRUG REVIEW PROCESS

Abstract

Investigational New Drug (IND) review process begins from the time the sponsor files investigation new drug application and the purpose of the review is to confirm the safety and efficacy of the patient for the drug. Moreover in the process of review if the review committee notifies any deficiencies by the new drug then there will be a clinical however if there are no deficiencies the drug will be approved for new drug application and will be under continuous review to make sure , that the drug does not cause any potential harm. This entire step wise process of review is explained in the following paper

INVESTIGATIONAL NEW DRUG REVIEW PROCESS

The following flow chart gives an overview of the IND review process
Applicant (Drug Sponsor)

IND

Review by CDER
Statistical
Pharmacology/ Toxicology
Medical
Chemistry

Sponsor Submits New Data
Safety Review

Safety acceptable for study to proceed Clinical Hold Decision

Notify Sponsor

Complete reviews

Reviews Complete and Acceptable?
Sponsor Notified of Deficiencies

No Deficiencies
Study Ongoing

INVESTIGATIONAL NEW DRUG REVIEW PROCESS

I. Applicant (Drug sponsor): An applicant or the sponsor is a person or a group who takes responsibility and initiates for the investigation of new drug. A person other than an individual that uses one or more of its own employees to conduct an investigation that it has initiated is a sponsor. The sponsor may be an individual, partnership, government agency, private agency, or any other organization and moreover the sponsor does not conduct the investigation process unless the sponsor is a sponsor-investigator. The...

Similar Documents

Premium Essay

Agencies

...contracted by a sponsor or client to perform several functions and duties related to clinical trials. (Kaluzny & McLaughlin, 2006, p. 319) The clinical trials are designed to obtain regulatory approval to market new pharmaceutical or biotechnology products. (Kaluzny & McLaughlin, 2006, p. 319) The services they perform for such clients as pharmaceutical companies include: “consulting and advice related to the design of drug development programs to labor-intensive services that are part of the drug development process; these include clinical monitoring of investigational sites, data management and statistical analysis, and presentations of regulatory submissions for review by regulatory agencies such as the U.S. Food and Drug Administration”. (Kaluzny & McLaughlin, 2006, p. 319) The FDA in the United States clearly mandate practices to protect the public’s health by implementing laws, regulations, and guidelines that provide oversight of the drug development process. (Kaluzny & McLaughlin, 2006, p. 322) The FDA requires the CRO to complete an IND or investigational New Drug application. “The pharmaceutical industry sometimes seeks advice from the FDA prior to submission of an IND”. (The FDA’s Drug Review Process, 2011) Throughout the whole process the FDA participates or more like regulates these clinical trials. The CROs as well as the...

Words: 611 - Pages: 3

Free Essay

Lab to Market

...development of new drugs and new research to use these drugs effectively. Drug companies run a substantial amount of tests before finding one that works effectively through all the different phases of testing. The process of drug approval is controlled in most countries by a governmental regulatory agency. In the U.S., the Food and Drug Administration (FDA) governs this process. The FDA requires the following phases to be achieved successfully before a drug can be sent to market, preclinical testing, investigational new drug application, phases I clinical trials, phase II clinical trials, phases III clinical trials, new drug application, and post marketing studies. A preclinical trial is the testing that begins before human testing can be conducted and which important feasibility, iterative testing and drug safety data is collected. This type of data research allows scientists to come up with a safe dosage for humans; typically this is done with animal testing. These tests can usually take around 3 to 4 years, before moving on to the next step. If there are no adverse effects then the drug moves on to the next step, which is investigational new drug application (IND). The pharmaceutical company files an IND with the FDA to begin testing the drug in people. The IND becomes effective if the FDA does not disapprove it within 30 days (medicine.net, 1999). The IND must include the following information: the results of previous experiments; how, where and by whom the new......

Words: 686 - Pages: 3

Premium Essay

Quiz Results - Informed Consent

...You correctly answered 1 of 5 and received 1 of 5 possible points. Scroll down to review the quiz questions and the explanation of the answers. Question 1 Question : An elderly gentleman, whose wife is his legally authorized representative since his strokes several years ago, was recently diagnosed with lung cancer. He is eligible for a clinical trial using a new investigational drug that aims to treat lung cancer. He is able to express interest, shows a basic understanding of the nature of the trial, and gives his assent to participation. The subject's wife is out of town on a business trip. Which of the following is the most appropriate action to take for the investigator? Your answer : The investigator can go ahead and enroll the man without a signed consent. Correct Answer : Send a copy of the informed consent via facsimile to the subject's wife. After she has had the opportunity to speak to the investigator, she can sign the informed consent and fax it back. Comment : The IRB will not provide a waiver of consent under these circumstances and the man should not be excluded from the study simply because his legally authorized representative is temporarily unavailable to sign in person. Verbal approval does not satisfy the FDA requirement at 21 CFR 56.109(c) of signed informed consent document. When obtaining consent from a legally authorized representative (LAR) who is not able to provide signed consent in person, it is acceptable to send the informed......

Words: 1119 - Pages: 5

Premium Essay

Fda Approvals for Medical Trials

... FDA Approval process for Clinical Trials If you, or someone you loved, were diagnosed with a terminal disease, would you chance using a non-FDA approved medication to increase your life expectancy? Many pharmaceutical companies have the medication that could save countless lives, but the FDA clinical trials for these medicines are problematic for enrollment, and thousands of patients are often turned down. New drugs are vitally important to improving the lives and health of Americans. Between 1986 and 2000, new drugs were responsible for 40 percent of the total increase in life expectancy. Yet, the FDA’s clinical trial process remains lengthy and expensive. It takes, on average, more than a decade to bring a new drug from the laboratory to the market. Polls show a clear majority of specialists believe the FDA clinical trial process is too slow and most report having been personally hindered in treating a patient due to the FDA approval process. The clinical trial process initiates when a drug developer submits an Investigational New Drug Application (IND) to the FDA. The IND application includes all available data on the proposed investigational drug, including the results of any animal testing. In reviewing IND applications, the FDA seeks to ensure that the proposed trial does not expose patients to “unreasonable risk of harm.” Clinical trials then move ahead in three mandatory human testing phases. Phase I consists of giving the investigational drug to a smaller......

Words: 2316 - Pages: 10

Premium Essay

Clinical Trials for New Drugs. Therapies and Medical Equipment

...Clinical Trials for New drugs. Therapies and Medical equipment The process for a new drug can take years and several stages to be approved by the FDA (Food and Drug Administration). Although most drugs are tested for specific kinds of diseases they might often have disappointing results for a specific disease but may have great results for another. The FDA has twelve stages of drug development and Review; these are important procedures before and after clinical trials. The twelve stages of drug development fall into the FDA’s four categories: pre-clinical, clinical, NDA (New Drug Application) review and post marketing. In the pre-clinical category there are two stages; animals tested and IND (Investigational New Drug) Application. The drug sponsor, companies/research institutions responsible for developing a drug, develops a new drug and seeks to have it approved by the FDA. Once the drug has been developed the sponsor has to test the new drug on animals for levels of toxicity, safety and efficacy of the drug. The sponsor then must submit an IND application and must include the results from animal testing. When the FDA approves of the new drug they make sure that it is completely safe to proceed and test on humans. In most cases drugs that have gone through the pre-clinical testing never actually make it to the human testing phase or are reviewed by the FDA. If the new drug is approved for human testing the research moves on to the clinical category, aka......

Words: 887 - Pages: 4

Premium Essay

Rm Citi Modules

...to the problems with the IRB system, the death of Jesse Gelsinger was what received public attention.) Which of the following is included in the Nuremberg Code? Voluntary Consent Informed consent is considered an application of which Belmont principle? **** Respect for Persons (Respect for persons involves respecting individual autonomy in the decision to participate in research. That respect is implemented through the process of informed consent) How should the investigator proceed, with respect to the IRB, after the discovery of the adverse event occurrence? Report the adverse drug experience in a timely manner, in keeping with the IRB's policies and procedures, using the forms or the mechanism provided by the IRB. How long is an investigator required to keep consent documents, IRB correspondence & research records? For a minimum of three years after completion of the study. (May be required to keep them longer than 3 years) According to federal regulations, which of the following best describes when expedited review of a new, proposed study may be used by the IRB? The study involves no more than minimal risk &...

Words: 1292 - Pages: 6

Premium Essay

Fundamentals of Research Paper

...Research Paper BSHS/382 Define the scientific method. The scientific method has its foundation in a number of steps including research, observational analysis and establishing data-driven rulings. Tell how it relates to human services research. Based on substantiation research studies, medical treatments and newer drugs are not only sustained but also adapted and improved over time. Exclusive of scientific research, their formation and effectiveness regulation will not be achievable. What are the steps in the process of scientific inquiry? Why must each of these steps be included to support the scientific method? Provide a human services research example of the scientific method and identify each step within your example 1. The first step in executing a scientific examination for research in a given field of study. It ascends and takes a solid shape, once a trained researcher figures out that some evidence may be necessary but is missing, and to study such information, the researcher proposes the research setback.
 2. Then occur, set up of variables and investigational conditions. 
 3. This is trailed by choosing or indiscriminately assigning qualified participants, under controlled laboratory and research conditions, to their individual experimental groups. 
 4. The variables are expended in distinctive variations, along with the treatment to be tested, and their endings are noted in a continuing...

Words: 859 - Pages: 4

Free Essay

The Potential Risk Involved in Bringing a New Pharmaceutical Drug to the Market

...The potential risk involved in bringing a new pharmaceutical drug to the market is huge. The actual timescale of the project is longer then a decade, and the success rate is around 1 in a 1000. In fact for every 1000 compounds that are produced only around 30 of these show any sort of promising result. Therefore introducing a new drug into the market does not simply involved one idea and one compound but in fact a complexed process of trial and error so to speak. After years of research on difference compounds have taken place the company can then progress to a stage know as the ‘preclinical stage’. This is where animals are tested upon and it is also the initial stage in the labs. The time scale varies from 3 and a half to four years and the main aim of this stage is to look at the biological activity of the compound and also to evaluate its safety. After the animal testing has been completed they company are not allowed to start testing on humans until their investigational new drug application (IND) has been approved. The company have to file a IND with the FDA, they do so to gain approval to start the next stage, which is on humans. The FDA has 30 days to disapprove. The investigation carried out looks at previous experiments and also information on the new study being evaluated i.e. how is conducting the study, where it is taking place etc. They also look at the chemical structure of the new drug and what its new purpose will be in the market. The next stage of......

Words: 827 - Pages: 4

Premium Essay

Mcs Submission Guidelines

...June 9-13, 2012 – Baltimore, Maryland 2012 ASHP Summer Meeting Management Case Study Submission and Format Guidelines Management Case Studies are 20-minute platform presentations followed by a 10-minute question and answer period. ASHP is seeking management case studies in specific topic areas: • Informatics • Leadership / Administration • Medication Safety • Clinical Conundrums This document will assist you in the preparation of your submission for a Management Case Study (MCS). The number of accepted management case studies will be limited and it is anticipated to be a highly competitive process. Each primary author is allowed only one submission. Due to ACPE Standards regarding active learning, a standard format will be required for final slide presentations which will utilize the learning objectives and self-assessment questions that you prepare for your submission. Thank you for your interest in presenting at the 2012 ASHP Summer Meeting! For assistance with preparing learning objectives and self-assessment questions, visit: http://www.ashp.org/menu/Education/OnlinePrograms.aspx and select ‘Education’ from the drop-down menu What is a Management Case Study? Introduction • The case study method was pioneered by the Harvard Business School in the early 1900s and still stands as a popular and effective teaching strategy in business education. • • The case method relies on information about people and events in a true-to-life situation that represents a problem to be......

Words: 1988 - Pages: 8

Premium Essay

The Food and Drug Administration

...The Food and Drug Administration, also known as the FDA or USFDA, is responsible for protecting and advocating public health. They are the official government agency that ensures our drug supply is safe and effective. This is achieved through the regulation and supervision of food safety, dietary supplements, veterinary products, cosmetics, vaccines, biopharmaceuticals, medical devices, prescription and pharmaceutical drugs that can be purchased over- the- counter. When a pharmaceutical company creates a new drug, it has to go through the FDA and is required to submit a New Drug Application (NDA) to the FDA. The FDA reviews the application to assure that there is an objective proof that the proposed drug is safe and effective. If the drug proves to be effective and safe, the FDA will approve it. However, the FDA requires some drugs to be furthered studied and require additional clinical trials. When the drug is officially approved, the FDA sends an approval letter to the company- this process may take many years. Some important steps taken for an approval are (2008 Internet Drug News Inc.): Synthesis & Purification - FDA estimates that it takes approximately eight-and-a-half years to study and test a new drug before it can be approved for the general public. This estimate includes early laboratory and animal testing, as well as later clinical trials using human subjects. Animal Testing (short term) - Generally, two or more species (one rodent, one non-rodent) are......

Words: 877 - Pages: 4

Premium Essay

Clinical Trials

...PHASES OF CLINICAL TRIALS Introduction Clinical Trial Definition: “Clinical trial” means a systematic study of new drug(s) in human subject(s) to generate data for discovering and / or verifying the clinical, pharmacological (including pharmacodynamic and pharmacokinetic) and /or adverse effects with the objective of determining safety and / or efficacy of the new drug. “ Drug Development Process: The process of drug development can be broadly classified as pre-clinical and clinical Pre- clinical refers to experimentation that occurs before it is given to human subjects; whereas, clinical refers to experimentation with humans. Within the realm of clinical research, clinical trials are classified into four phases. [pic] Classification of Various phases of clinical trials: There are five different phases of clinical trials, which include: ➢ Phase 0 Trials (Micro dosing trials) ➢ Phase I Trials (Human Pharmacology/ First time in Man Studies) ➢ Phase II Trials (Pilot Trials/ Therapeutic Exploratory trials) ➢ Phase III Trials ( Expanded clinical trials/Therapeutic Confirmatory trials) ➢ Phase IV Trials ( Post Marketing trials) 1. Phase 0 Trails/Micro dosing Trials: Micro dosing, or human phase 0 clinical trials, is a technique whereby sub pharmacological doses of prospective drug candidates are administered to human volunteers. A micro dose study provides early pharmacokinetic data in humans and only requires minimal......

Words: 1463 - Pages: 6

Premium Essay

Fda Approvals

...Food and Drug Agency’s Drug Approval Process Abstract The drug approval process of the Food and Drug Agency for pharmaceuticals is a complex and often lengthy one. Done out of necessity to ensure the products being introduced into the growing healthcare field are overall safe and effective for utilization by patients. While the process is far from perfect it still a staple in introducing innovative and breakthrough drugs into healthcare fields across the board. This paper will discuss the process encountered to get pharmaceuticals approved for manufacture and distribution to physicians and patients. Food and Drug Agency’s Drug Approval Process “For healthcare technology, the most important regulatory approval comes from the federal Food and Drug Administration (FDA)” (Williams & Torrens, 2008, pg.28). This agency approves all drugs and pharmaceuticals, medical devices, and some medical equipment. The FDA also controls access to drugs by deciding whether a certain drug will be available by prescription only or as an over-the-counter purchase (Shi & Singh, 2013, pg.115). The most well-known regulatory review of medical technology is that conducted on pharmaceutical products and to some medical devices that are subjected to detailed preliminary approvals, clinical trials, and post-approval surveillance policies. Before a drug can begin (first phase) clinical testing, the sponsor of the drug must evaluate the product’s safety and biological activity via in vitro......

Words: 911 - Pages: 4

Premium Essay

New Pharmaceuticals

...2000 B.C. Since then, the drug market and its vendors have definitely skyrocketed. Pharmaceuticals are regulated by the Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) and steps are required to bring new drugs into the market. FDA specific guidelines for new pharmaceuticals are essential because it determines a drug’s safety and effectiveness. To support this thesis an overview of steps required to market a new pharmaceutical will be discussed as well as human testing of drugs, the role of FDA in approving new drugs, and the cost incurred by drug companies when developing new drugs. Pharmaceutical development can be divided into segments. The first segment is the preclinical phase; this is where the drug company attempts to breakdown a disease process into components so it can provide clues for targeting new drug development and usually takes three to four years to complete (Lipsky & Sharp, 2001). Once a new drug has been chosen and developed, the FDA requires that animal tests be performed. In vivo testing, typically done to rodents, demonstrates the safety of the prospective medication and also to notes and evaluates any side or toxic effects, addictions, cancerous tumors, and/or fetal deformities (Turley, 2010, p. 27). The results from the animal studies, indicating no risk to humans, will then be used to support the investigational new drug application (IND) to the FDA to request permission to test the drug in humans (Turley, 2010, p...

Words: 989 - Pages: 4

Premium Essay

The Public Needs to Know

...English Composition 115 | Professor Charlotte Walker | | Jamie Mahan | 11/21/2013 | “The economic impact of cancer care has increasingly been the target of scrutiny because of the large price tag attached to many of the agents that have become available during the past few years, especially the biologics.” (Nelson, Roxanne, 2008). If the cost of cancer care keeps rising, the doctors are going to have to include costs when it comes to the decision-making process. The doctors are going to have to think about the actual benefits associated with the expensive treatment. The development of new cancer drugs can be an expensive and lengthy process for cancer patients. Cancer Costs More Than Doubled Since ‘90 Cancer research has cost the US government $100 billion since 1971, and the price of care, accounting for inflation, has more than doubled to $90 billion since 1990. “The price of the drugs, and the care tied to their use, can be lowered by shifting to a system which the costs of drugs, tests, and other care are combined in a single-provider payment,” researchers said. Patients concerns about out-of-pocket payments made patients decide how to treat their cancer. Patients that have health insurance have used most or all of their savings to treat their cancer. “We’ve made progress in cancer research, but people are still dying at too high a rate,” (Gibson, 2010). ...

Words: 841 - Pages: 4

Premium Essay

Mr. Smaygj

...for Drug Evaluation and Research Food and Drug Administration Focus Why quality by design? Where are we in preparing for quality by design in CMC review programs (implementation an industry activity) Opportunities and challenges State of Pharmaceutical Manufacturing In many cases, not state-of-art as compared to other industries Able to achieve reasonable product quality – but at a great effort and cost Little emphasis on manufacturing – mainly on development although manufacturing is approximately 25% of expenses For some products, waste as high as 50% Inability to predict effects of scale up on final product Inability to analyze or understand reasons for manufacturing failures Globally fragmented Consequences High cost for products due to Low efficiencies in manufacturing Waste Manufacturing time requirements based on testing, etc. Drug shortages due to manufacturing problems Lack of improvements based on new technologies Slowed development/access for investigational drugs Need for intensive regulatory oversight State of Regulatory Quality Review Processes Oversight increased – reviewed every change made – increased number of application supplements Focused on chemistry but not on other important areas (e.g., engineering) Implemented numerous changes in process to facilitate increasing review requirements (SUPAC, BACPAC) Issued numerous “how to” guidances (prescriptive) All standards internally developed PDUFA requirements speed up review process......

Words: 1191 - Pages: 5